Ethan Bickelhaupt, MD
Psychiatry · Topeka, KSNPI 1760427389
Payments from drug & device makers
Across 565 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$926
- Alkermes, Inc.$899
- Tris Pharma Inc$887
- plus $5K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $1,815 |
| Otsuka America Pharmaceutical, Inc. | 67 | $1,627 |
| Teva Pharmaceuticals USA, Inc. | 49 | $1,016 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 47 | $926 |
| Alkermes, Inc. | 40 | $899 |
| Tris Pharma Inc | 24 | $887 |
| Sunovion Pharmaceuticals Inc. | 24 | $706 |
| E.r. Squibb & Sons, L.L.C. | 14 | $634 |
| Supernus Pharmaceuticals, Inc. | 47 | $583 |
| Vanda Pharmaceuticals Inc. | 36 | $458 |
| Axsome Therapeutics, Inc. | 15 | $354 |
| Lundbeck LLC | 19 | $342 |
| Neurocrine Biosciences, Inc. | 12 | $332 |
| Johnson & Johnson | 13 | $287 |
| Bausch Health US, LLC | 13 | $218 |
| Neos Therapeutics, LP | 18 | $214 |
| Corium, LLC | 13 | $207 |
| Almatica Pharma LLC | 5 | $102 |
| Noven Therapeutics, LLC | 4 | $74 |
| Ironshore Pharmaceuticals Inc. | 3 | $54 |
| Eisai Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Biogen | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
How this compares
$11,959 in reported general payments places this provider in the 85th percentile of 259 psychiatry providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Topeka
- Debra KelshKansas City$25.2M
- Paul MurphyWichita$3.9M
- Matthew ByerlyWichita$792K
- David WichmanManhattan$613K
- Kevin MaysLeawood$558K
- Sheldon PreskornWichita$498K
- James OwensSalina$433K
- Tyler KjorvestadKansas City$124K
- Sasha HamdaniOverland Park$104K
- William JohnsonJunction City$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.